ICD-10-CM · General

M33.99

M33.99 identifies dermatopolymyositis of unspecified type accompanied by organ involvement that is neither respiratory nor limited to myopathy — a catch-all for systemic manifestations such as cardiac, gastrointestinal, or renal involvement when the subtype (juvenile vs. adult-onset) is not documented.

Verified May 8, 2026 · 6 sources ↓

Status
Billable
Chapter
13
Related CPT
5
Region
General
Drawn from CDCICD10DataCMSOutsourcestrategiesAAPC

Documentation tips

What should appear in the chart to support M33.99.

Source · Editorial brief grounded in 6 cited references ↓

  • Specify whether the condition is juvenile-onset or adult-onset; if adult/other, use M33.19 instead of M33.99.
  • Name the organ system involved (e.g., cardiac, esophageal, gastrointestinal, renal) to justify 'other organ involvement' over the more specific respiratory (M33.91) or myopathy (M33.92) subcodes.
  • Add secondary codes for each documented manifestation — for example, esophageal dysmotility, interstitial lung disease, or cardiomyopathy — to fully capture disease burden and support medical necessity.
  • Record lab findings (elevated CK, aldolase, ANA, anti-Jo-1, anti-MDA5) and EMG or muscle biopsy results that confirm the diagnosis and support the systemic severity.
  • Document why the dermatomyositis subtype cannot be classified as juvenile (M33.0x) or 'other dermatomyositis' (M33.1x) if the record is ambiguous — query the treating rheumatologist if needed.

Related CPT procedures

Procedure codes commonly billed with M33.99. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M33.99 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

  • Defaulting to M33.99 for all adult dermatomyositis with organ involvement — if the provider documents 'dermatomyositis' without specifying juvenile, adult-onset dermatomyositis typically maps to M33.1x (Other dermatomyositis), making M33.19 the correct code, not M33.99.
  • Using the non-billable parent M33.9 or M33.90 instead of drilling down to M33.99 when other organ involvement is documented — M33.9 will not pass claim edits requiring a billable code.
  • Omitting secondary diagnosis codes for the specific organs involved, leaving the 'other organ involvement' qualifier unsupported in the record and increasing audit risk.
  • Assigning M33.99 alongside amniotic/placental-derived injection CPT codes — CMS LCD A58865 explicitly lists M33.99 as not supporting medical necessity for those procedures, which will trigger denial.

Clinical context

Source · Editorial summary grounded in 6 cited references ↓

M33.99 sits at the bottom of the M33.9 (Dermatopolymyositis, unspecified) subcategory and is the correct billable code when the clinician documents systemic organ involvement beyond lungs or muscle but does not specify whether the condition is juvenile (M33.0x) or adult/other dermatomyositis (M33.1x). Typical scenarios include a rheumatology consult note referencing cardiac involvement, dysphagia from esophageal dysmotility, or interstitial lung disease that doesn't match M33.91's respiratory-specific slot — combined with a diagnosis of dermatopolymyositis where juvenile vs. adult classification is absent.

The 'unspecified' designation in this code carries a dual liability: it signals both that the dermatomyositis subtype is undocumented AND that the organ involvement is something other than respiratory or myopathy. Before assigning M33.99, exhaust whether the record supports a more specific parent: M33.09 (juvenile with other organ involvement), M33.19 (other dermatomyositis with other organ involvement), or M33.29 (polymyositis with other organ involvement). If the clinician distinguishes adult-onset dermatomyositis, M33.19 is correct — M33.99 is not a fallback for adult cases.

CMS explicitly lists M33.99 among ICD-10-CM codes that do NOT support medical necessity for amniotic and placental-derived product injections for musculoskeletal indications (LCD A58865). Be aware that payers may scrutinize claims pairing M33.99 with musculoskeletal injection procedures. Additional codes for specific manifestations (e.g., J84.10 for pulmonary fibrosis, or codes for cardiac or GI complications) should accompany M33.99 when documented.

Sibling codes

Other billable codes under M33.9 (laterality / anatomic variants).

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 6 cited references ↓

01When should I use M33.99 instead of M33.19?
Use M33.19 when the provider documents 'other dermatomyositis' or adult-onset dermatomyositis with organ involvement other than respiratory or myopathy. Reserve M33.99 for cases where the dermatomyositis subtype is genuinely unspecified — not documented as juvenile, adult, or polymyositis — combined with other organ involvement.
02Is M33.99 billable for FY2026?
Yes. M33.99 is a billable, specific ICD-10-CM code effective October 1, 2025 under the FY2026 code set. Its parent, M33.9, is not billable and should not appear on claims.
03What counts as 'other organ involvement' for M33.99?
Any systemic manifestation that is not respiratory (M33.91) and not limited to myopathy (M33.92) — such as cardiac involvement, esophageal dysmotility, gastrointestinal dysmotility, renal involvement, or hepatic involvement. Document the specific organ; do not rely on M33.99 alone to convey clinical severity.
04Will M33.99 support medical necessity for joint injections?
No. CMS LCD A58865 explicitly lists M33.99 as a code that does NOT support medical necessity for amniotic and placental-derived product injections for musculoskeletal indications. Claims pairing M33.99 with those procedures will be denied.
05Should I add secondary codes when using M33.99?
Yes. Code also the specific organ manifestations — for example, J84.10 for pulmonary fibrosis or applicable cardiac or GI codes — to fully represent disease burden, satisfy payer documentation requirements, and reduce audit exposure from an otherwise vague 'other organ involvement' designation.
06What is the difference between M33.99 and M33.90?
M33.90 is used when organ involvement is unspecified — meaning the record does not indicate which organ systems are affected. M33.99 is used when the record documents involvement of a specific organ other than the lungs or muscle. If any organ involvement is documented, M33.90 is incorrect.
07Does M33.99 require a 7th-character extension?
No. M33.99 is an M-code (chronic disease) and does not use 7th-character encounter extensions. Those extensions (A, D, S) apply to injury S-codes only.

Mira AI Scribe

Mira AI Scribe captures the treating clinician's documentation of dermatomyositis subtype (juvenile vs. adult-onset vs. unspecified), the specific organs involved beyond lungs and muscle, relevant lab markers (CK, ANA, myositis-specific antibodies), and any imaging or biopsy results — preventing the unspecified fallback to M33.90 and flagging when the record supports a more precise code such as M33.19 or M33.09.

See how Mira captures M33.99 documentation

Related ICD-10 codes

Ready?

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Get started for free